References
- Robins LN, Helzer JE, Weissman MM. et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984: 41(10): 949–58
- Thyer BA, Parrish RT, Curtis GC, et al. Ages of onset of DSM-III anxiety disorders. Compr Psychiatry 1985: 26(2): 113–22
- Goodwin DW, Guze SB, Robins E. Follow-up studies in obsessional neurosis. Arch Gen Psychiatry 1969: 20(2): 182–7
- Foa EB, Grayson JB, Steketee GS, et al. Success and failure in the behavioral treatment of obsessive compulsives. J Consult Clin Psychol 1983: 51(2): 287–97
- Stern RS. Obsessive thoughts: the problem of therapy. Br J Psychiatry 1978: 133(Sep): 200–5
- Rifkin A. Depression: management tips for the primary care physician. Postgrad Med 1988: 83(2): 111–8
- Montgomery SA. Clomipramine in obsessional neurosis: a placebo-controlled trial. Pharm Med 1980: 1: 189–92
- Marks IM, Stern RS, Mawson D, et al. Clomipramine and exposure for obsessive-compulsive rituals. Br J Psychiatry 1980: 136(Jan): 1–25
- Thoren P, Asberg M. Cronholm B, et al. Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. Arch Gen Psychiatry 1980: 37(11): 1281–5
- Ananth J, Pecknold JC, van den Steen N, et al. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Prog Neuropsychopharmacol 1981: 5(3): 257–62
- Insel TR, Murphy DL, Cohen RM, et al. Obsessive-compulsive disorder: a double-blind trial of clomipramine and clorgyline. Arch Gen Psychiatry 1983: 40(6): 605–12
- Volavka J, Neziroglu F, Yaryura-Tobias JA. Clomipramine and imipramine in obsessive-compulsive disorder. Psychiatry Res 1985: 14(1): 85–93
- Stern RS, Marks IM, Wright J, et al. Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis. Postgrad Med J 1980: 56(Suppl 1): 134–9
- Baxter LR Jr. Two cases of obsessive-compulsive disorder with depression responsive to trazodone. J Nerv Ment Dis 1985: 173(7): 432–3
- Prasad A. Efficacy of trazodone as an antiobsessional agent. Pharmacol Biochem Behav 1985: 22(2): 347–8
- Fontain R. Chouinard G, Iny L. An open clinical trial of zimelldine in the treatment of obsessive-compulsive disorder. Curr Ther Res 1985: 37: 326–32
- Perse TL, Greist JH, Jefferson JW, et al. Fluvoxamine treatment of obsessive-compulsive disorder. Am J Psychiatry 1987: 144(12): 1543–8
- Price LH, Goodman WK, Charney DS, et al. Treatment of severe obsessive-compulsive disorder with fluvoxamine. Am J Psychiatry 1987: 144(8): 1059–61
- Kelly D. Walter CJ, Mitchell-Heggs N, et al. Modified leucotomy assessed clinically, physiologically and psychologically at six weeks and eighteen months. Br J Psychiatry 1972: 120(554): 19–29
- Kelly D. Anxiety and emotions: physiological basis and treatment. Springfield, IL: CC Thomas. 1980 (American lectures in objective psychiatry. No. 1026)
- Strom-Olsen R, Carlisle S. Bi-frontal stereotactic tractotomy: a follow-up study of its effects on 210 patients. Br J Psychiatry 1971: 118(543): 141–54
- Tippin J, Henn FA. Modified leukotomy in the treatment of intractable obsessional neurosis. Am J Psychiatry 1982: 139(12): 1601–3
- Post F. Rees WL, Schurr PH. An evaluation of bimedial leucotomy. Br J Psychiatry 1968: 114(515): 1223–46
- Smith JS, Kiloh LG, Cochrane N, et al. A prospective evaluation of open prefrontal leucotomy. Med J Aust 1976: 1 (20): 731–733, 735